ID: ALA3648903

Max Phase: Preclinical

Molecular Formula: C26H33N5O5S

Molecular Weight: 527.65

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCN1CCN([C@@H](CNS(=O)(=O)c2ccc(OCc3cc(C)nc4ccccc34)cc2)C(=O)NO)CC1

Standard InChI:  InChI=1S/C26H33N5O5S/c1-3-30-12-14-31(15-13-30)25(26(32)29-33)17-27-37(34,35)22-10-8-21(9-11-22)36-18-20-16-19(2)28-24-7-5-4-6-23(20)24/h4-11,16,25,27,33H,3,12-15,17-18H2,1-2H3,(H,29,32)/t25-/m0/s1

Standard InChI Key:  UFNKXVJYCDHZQW-VWLOTQADSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 527.65

Molecular Weight (Monoisotopic): 527.2202

AlogP: 1.91

#Rotatable Bonds: 10

Polar Surface Area: 124.10

Molecular Species: NEUTRAL

HBA: 8

HBD: 3

#RO5 Violations: 1

HBA (Lipinski): 10

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 8.72

CX Basic pKa: 7.29

CX LogP: 1.60

CX LogD: 1.48

Aromatic Rings: 3

Heavy Atoms: 37

QED Weighted: 0.27

Np Likeness Score: -1.44

References

1.  (2014)  Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics, 

2.  (2016)  Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics, 

Source

Source(1):

• BindingDB Database